Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 1,261-1,272 of 1,909
Other study type icon
Not recruitingISRCTN72151939

Pramipexole study for Depression in bipolarity

This study is looking at whether a digital support tool can help people with Treatment-resistant Depression in bipolarity, Mental and Behavioural Disorders, or Bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionOtherOver 18 Years
Countries
United Kingdom
Sponsor
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust
Condition
Bipolarity, Depression
Drug study icon
Not recruitingISRCTN33631053

The Oxford study of calcium channel antagonism, cognition, mood instability and sleep

This study is looking at whether The intervention is nicardipine or placebo can help people with Mood instability, which is a feature of bipolarity and other mental health conditions including borderline personality disorder, but can also occur in the absence of any diagnosis or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study includes Bipolarity among several conditions.

BipolarityOtherOver 18 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Bipolarity
Drug study icon
Not recruitingISRCTN16011816

Trans cranial magnetic stimulation in Depression in bipolarity

e. with Depression in bipolarity who did not respond to two or more adequately dosed medication trials, Mental and Behavioural Disorders, or Bipolarity.

In Netherlands
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionOtherOver 18 Years
Countries
Netherlands
Sponsor
Amsterdam UMC Location VUmc
Condition
Bipolarity, Depression
Device study icon
Not recruitingISRCTN77188420

Transcranial magnetic stimulation in the treatment of Depression in bipolarity

This study is looking at whether a digital support tool can help people with Bipolar I or II disorder, current episode depressive, moderate to severe, without psychotic symptoms, Mental and Behavioural Disorders, or Bipolarity, current episode mild or moderate depression, Bipolarity, current episode severe depression without psychotic symptoms. Participants take part in a digital support tool and complete follow-up assessments.

In Czech Republic
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, Depression, ...OtherFrom 18 Years to 110 Years
Countries
Czechia
Sponsor
National Institute of Mental Health
Condition
Bipolarity, Depression, ...
Drug study icon
CompletedEUCTR 2018-002749-12

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Adjunctive to Lithium or Valproate in the Treatment of Patients with Major D...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.
Countries
Bulgaria
Sponsor
Intra-Cellular Therapies, Inc. (ITI)
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2019-004440-29

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients with Major Depressive Episodes...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDrug
Countries
Bulgaria
Sponsor
Intra-Cellular Therapies, Inc. (ITI)
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT00217165

Taurine as an Anti-Manic Agent: A Study

This study is completed in the United States. It focuses on Bipolarity.

In Belmont
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 68 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2008-007483-42

A 24-Week, Flexible-Dose, Open-label Extension Study of Lurasidone for the Treatment of Bipolar I Depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrug
Countries
France, Czechia, Germany, ...
Sponsor
Sunovion Pharmaceuticals Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2011-002334-39

A Double-blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar Depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrug
Countries
Bulgaria
Sponsor
Forest Research Institute, Inc
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2009-010276-16

A Long-Term, Open-Label, Safety Study of Oral Olanzapine in Adolescents with Bipolarity type I (Manic or Mixed Episodes) or Schizophrenia

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaDrug
Countries
Germany
Sponsor
Eli Lilly
Condition
Bipolarity, Schizophrenia
Drug study icon
TerminatedEUCTR 2021-006861-39

A Phase 2 Clinical Trial of GH001 in Patients with Bipolarity type II and a Current Major Depressive Episode (GH001-BD-202)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrug
Countries
Germany, Netherlands
Sponsor
GH Research Ireland Limited
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.